Recent research suggests the lymphocyte-suppressive effect of dexamethasone may underlie the glucocorticoid’s effect on building trabecular bone density
The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology
Information technology an overarching theme of this year’s work
Atypical Fractures Associated with Bisphosphonates
Plus, FX006, odanacatib and other rheumatology drug news, safety updates
Persistent Symptomatic Hypocalcemia Due to Denosumab: A Case Review
Patients with osteoporosis and impaired renal function are at risk
Orexin’s Yin/Yang Functions Regulate Bone Remodeling
Working both to support bone formation and suppress it, a new study reveals orexin neuropeptides are essential regulators of skeletal homeostasis
New Osteoporosis Drugs Show Promise in Therapy Pipeline
Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options
New Treatments Needed to Prevent Fractures in Osteoporosis
Current therapies target pathways of bone remodeling, but rheumatologists say a better understanding of the mechanisms of bone resorption, formation is needed to make an impact
Rheumatologists on the Move
Awards, appointments and announcements in the world of rheumatology
U.S. Bone and Joint Initiative Summit Examines Quality of Patient-Centered Musculoskeletal Care
Physicians discuss definition, implementation of best clinical practices for patient care at multidisciplinary meeting last November
Rheumatology Drug Updates, Trials, Safety Data
Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 19
- Next Page »